ISPOR Latin America 2019 | Short Course and Spotlight Session
At ISPOR Latin America 2019, NESTcc Data Network Director Robert Zusterzeel, MD, PhD, MPH, presents as faculty for the short course “Evaluation of Medical Devices: How to Manage HTAs” and as a panelist in the spotlight session “Defining Value in Medical Devices: ‘The Stakeholder Matters.’”
The leading HEOR Conference in the region, ISPOR Latin America 2019 draws more than 1,000 professionals from the regional global health care community on September 12-14 to explore key issues surrounding the theme of “Data and Value in Healthcare: 2020 and beyond.
SHORT COURSE | Evaluation of Medical Devices – How to Manage HTAs
Thursday, September 12
8 a.m. to 12 p.m.
Rooms Ñ-O (3rd Floor/Piso 3)
OVERVIEW
The objective of this short course is to promote understanding of the key challenges associated with the evaluation of medical devices for HTA and provide robust alternative solutions.
The course will begin by exploring core differences between HTA for drugs and medical devices. We will reflect on the international experience on evaluation of medical devices for HTA and compare this with the approaches currently implemented by HTA agencies in Latin America to evaluate these health technologies. Exemplary case studies will be used to illustrate potential solutions to key methodological challenges in the evaluation of medical devices for HTA. The potential contribution of real-world evidence and real-world data to address core methodological issues associated with medical device evaluation for HTA will be considered.
Participants will have the opportunity to apply the theoretical concepts considered in the lectures by developing a protocol for HTA evaluation of a medical device. By the end of the course, participants will have a clear understanding of core challenges associated with HTA evaluation of medical devices and information on robust alternative methods to address these.
FACULTY
- Ramiro E. Gilardino, MD, MHE, MSc
ISPOR, Lawrenceville, NJ, USA - Cynthia P. Iglesias, MSc, PhD
University of York, Heslington, York, United Kingdom - Robbert Zusterzeel, MD, PhD, MPH
National Evaluation System for Health Technology Coordinating Center (NESTcc), Arlington, VA, USA
SPOTLIGHT SESSION | Defining Value in Medical Devices: “The Stakeholder Matters”
Friday, September 13
3 p.m. to 4 p.m.
Rooms TU-VW (5th Floor/Piso 5)
ISSUE
The medical device market is growing faster than the pharmaceutical one. A large and growing middle class in Latin American has been identified as a key emerging market. Ensuring access to medical technology associated with the highest value for money however is a priority for a broad range of stakeholders (e.g. regulators, HTA assessors, healthcare providers, payers and patients) across the healthcare ecosystem.
OVERVIEW
During the session a group of stakeholders will reflect on what makes a medical valuable for them. Panelist will describe their definition of value for medical devices, their views on what drives or should drive the adoption of innovative medical devices, and how these technologies should be assessed.
MODERATOR
- Cynthia P. Iglesias, MSc, PhD
University of York, Heslington, York, United Kingdom
PANELISTS
- Jaime Calderón, MD
Instituto de Evaluación Tecnológica en Salud, Bogotá, Colombia - Maria Gabriela Fernandez, PharmD
Juan Garrahan Pediatric Hospital, Buenos Aires, Argentina - Gabriela Prada, MHA
Medtronic, Ontario, Canada - Robbert Zusterzeel, MD, PhD, MPH
National Evaluation System for Health Technology Coordinating Center (NESTcc), Arlington, VA, USA
